This research report focuses on the At-Home Drug of Abuse (DOA) Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Test Cups
- 1.2.3 Test Dip Cards
- 1.2.4 Test Strips
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Urine
- 1.3.3 Saliva
- 1.3.4 Hair
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2017-2028)
- 2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
- 2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2017-2022)
- 2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028)
- 2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
- 2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
- 2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
- 2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
- 2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
- 3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2017-2022)
- 3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2017-2022)
- 3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
- 3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
- 3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2021
- 3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
- 3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
- 3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
- 4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2017-2022)
- 4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
- 5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2017-2022)
- 5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
- 6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
- 6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
- 6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
- 6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
- 6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
- 6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
- 6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
- 6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
- 6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
- 6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
- 6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
- 7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
- 7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
- 7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
- 7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
- 7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
- 7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
- 7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
- 7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
- 7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
- 7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
- 7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
- 8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type
- 8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
- 8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application
- 8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
- 8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
- 8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
- 9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
- 9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
- 9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
- 9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
- 9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
- 9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
- 9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
- 9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
- 9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
- 9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
- 9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
- 10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type
- 10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
- 10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application
- 10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
- 10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
- 10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 UCP Biosciences
- 11.1.1 UCP Biosciences Company Details
- 11.1.2 UCP Biosciences Business Overview
- 11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
- 11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.1.5 UCP Biosciences Recent Developments
- 11.2 Orient New Life Medical
- 11.2.1 Orient New Life Medical Company Details
- 11.2.2 Orient New Life Medical Business Overview
- 11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
- 11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.2.5 Orient New Life Medical Recent Developments
- 11.3 Express Diagnostics Int'l
- 11.3.1 Express Diagnostics Int'l Company Details
- 11.3.2 Express Diagnostics Int'l Business Overview
- 11.3.3 Express Diagnostics Int'l At-Home Drug of Abuse (DOA) Testing Introduction
- 11.3.4 Express Diagnostics Int'l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.3.5 Express Diagnostics Int'l Recent Developments
- 11.4 Assure Tech (Hangzhou)
- 11.4.1 Assure Tech (Hangzhou) Company Details
- 11.4.2 Assure Tech (Hangzhou) Business Overview
- 11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
- 11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.4.5 Assure Tech (Hangzhou) Recent Developments
- 11.5 Psychemedics Corporation
- 11.5.1 Psychemedics Corporation Company Details
- 11.5.2 Psychemedics Corporation Business Overview
- 11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
- 11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.5.5 Psychemedics Corporation Recent Developments
- 11.6 Confirm BioSciences
- 11.6.1 Confirm BioSciences Company Details
- 11.6.2 Confirm BioSciences Business Overview
- 11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
- 11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.6.5 Confirm BioSciences Recent Developments
- 11.7 Phamatech
- 11.7.1 Phamatech Company Details
- 11.7.2 Phamatech Business Overview
- 11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
- 11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.7.5 Phamatech Recent Developments
- 11.8 Home Health (U.K.) Ltd.
- 11.8.1 Home Health (U.K.) Ltd. Company Details
- 11.8.2 Home Health (U.K.) Ltd. Business Overview
- 11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
- 11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.8.5 Home Health (U.K.) Ltd. Recent Developments
- 11.9 Quest Products
- 11.9.1 Quest Products Company Details
- 11.9.2 Quest Products Business Overview
- 11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
- 11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
- 11.9.5 Quest Products Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer